Transarterial chemoembolization as adjuvant treatment after surgery: The cure of huge hepatocellular carcinoma?
被引量:1
摘要
Hepatocellular carcinoma(HCC) represents the sixth common cancer and the second leading cause of cancer-related death. Its incidence is higher in Eastern countries. HCC is frequently detected at advanced stage of disease, and therefore, the mortality is high [1].
参考文献5
-
1Han Wang,Hua Yu,You-Wen Qian,Zhen-Ying Cao,Meng-Chao Wu,Wen-Ming Cong.Postoperative adjuvant transcatheter arterial chemoembolization improves the prognosis of patients with huge hepatocellular carcinoma[J].Hepatobiliary & Pancreatic Diseases International,2021,20(3):232-239. 被引量:4
-
2Antonio Facciorusso,Gaetano Serviddio,Nicola Muscatiello.Transarterial radioembolization vs chemoembolization for hepatocarcinoma patients:A systematic review and metaanalysis[J].World Journal of Hepatology,2016,8(18):770-778. 被引量:5
-
3Qiang Fang,Qing-Song Xie,Jiang-Ming Chen,Shen-Liang Shan,Kun Xie,Xiao-Ping Geng,Fu-Bao Liu.Long-term outcomes after hepatectomy of huge hepatocellular carcinoma: A single-center experience in China[J].Hepatobiliary & Pancreatic Diseases International,2019,18(6):532-537. 被引量:13
-
4Antonio Facciorusso.Drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma: Current state of the art[J].World Journal of Gastroenterology,2018,24(2):161-169. 被引量:27
-
5Shao-Liang Zhu,Jian-Hong Zhong,Yang Ke,Liang Ma,Xue-Mei You,Le-Qun Li.Efficacy of hepatic resection vs transarterial chemoembolization for solitary huge hepatocellular carcinoma[J].World Journal of Gastroenterology,2015,21(32):9630-9637. 被引量:6
二级参考文献65
-
1Yifei Tan,Wei Zhang,Lunan Yan.Impact of anatomical resection for hepatocellular carcinoma with microportal invasion (vp1)[J].Hepatobiliary Surgery and Nutrition,2019,8(3):274-276. 被引量:1
-
2Han Wang,Peng-Cheng Du,Meng-Chao Wu,Wen-Ming Cong.Postoperative adjuvant transarterial chemoembolization for multinodular hepatocellular carcinoma within the Barcelona Clinic Liver Cancer early stage and microvascular invasion[J].Hepatobiliary Surgery and Nutrition,2018,7(6):418-428. 被引量:29
-
3Alexander J. Thompson,Andrew J. Muir,Mark S. Sulkowski,Dongliang Ge,Jacques Fellay,Kevin V. Shianna,Thomas Urban,Nezam H. Afdhal,Ira M. Jacobson,Rafael Esteban,Fred Poordad,Eric J. Lawitz,Jonathan McCone,Mitchell L. Shiffman,Greg W. Galler,William M. Lee,Robert Reindollar,John W. King,Paul Y. Kwo,Reem H. Ghalib,Bradley Freilich,Lisa M. Nyberg,Stefan Zeuzem,Thierry Poynard,David M. Vock,Karen S. Pieper,Keyur Patel,Hans L. Tillmann,Stephanie Noviello,Kenneth Koury,Lisa D. Pedicone,Clifford A. Brass,Janice K. Albrecht,David B. Goldstein,John G. McHutchison.Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus[J]. Gastroenterology . 2010 (1)
-
4David Moher,Alessandro Liberati,Jennifer Tetzlaff,Douglas G. Altman.Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement[J]. International Journal of Surgery . 2010 (5)
-
5Josep M. Llovet,Jordi Bruix.Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival[J]. Hepatology . 2003 (2)
-
6The liver Cancer Study Group of Japan.Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan[].Cancer.1994
-
7European Association for the Study of the Liver,European Organisation for Research and Treatment of Cancer.EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma[J].Journal of Hepatology.2012(4)
-
8Luigi Bolondi,Andrew Burroughs,Jean-Fran?ois Dufour,Peter Galle,Vincenzo Mazzaferro,Fabio Piscaglia,Jean Raoul,Bruno Sangro.Heterogeneity of Patients with Intermediate (BCLC B) Hepatocellular Carcinoma: Proposal for a Subclassification to Facilitate Treatment Decisions[J].Semin Liver Dis.2012(04)
-
9Josep M. Llovet,Jordi Bruix.Novel advancements in the management of hepatocellular carcinoma in 2008[J].Journal of Hepatology.2008
-
10Marta Burrel,María Reig,Alejandro Forner,Marta Barrufet,Carlos Rodríguez de Lope,Silvia Tremosini,Carmen Ayuso,Josep M Llovet,María Isabel Real,Jordi Bruix.Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design[J].Journal of Hepatology.2012(6)
共引文献49
-
1倪俊声,周伟平.以切缘为本的肝切除是提高原发性肝癌生存率的关键[J].肝胆外科杂志,2020(2):87-90. 被引量:7
-
2Sen Yang,Zhao Lai,Xue-Wen Wang,Jie Chen,Teng-Gang Deng.Effect of surgical resection combined with transcatheter arterial chemoembolization on postoperative serum tumor marker levels and stem cell characteristics during tumor recurrence[J].Journal of Hainan Medical University,2017,23(9):97-100.
-
3李铜强,石钦,熊斌.肝细胞癌动脉内治疗的研究进展[J].中华介入放射学电子杂志,2022,10(3):283-295.
-
4徐勤文,庞爱生.繁育苏镇、春光原原种的体会[J].江苏蚕业,2000,22(1):29-30.
-
5杨森,赖钊,王学文,陈杰,邓腾刚.手术切除联合肝动脉化疗栓塞对术后血清肿瘤标志物含量及肿瘤复发过程中干细胞特性的影响[J].海南医学院学报,2017,23(9):1244-1247. 被引量:6
-
6苗春木,丁雄,邓开,龚建平.MDT主导的BCLC B期肝右叶原发性巨块型肝癌TACE术后外科根治性切除的时机探讨[J].中国普外基础与临床杂志,2018,25(6):735-743. 被引量:8
-
7刘博智,袁筑慧,李威.经肝动脉化疗栓塞术联合射频消融治疗巨大肝细胞癌1例报告[J].临床肝胆病杂志,2018,34(7):1520-1522. 被引量:1
-
8Yi Yang,Tongguo Si.Yttrium-90 transarterial radioembolization versus conventional transarterial chemoembolization for patients with hepatocellular carcinoma:a systematic review and meta-analysis[J].Cancer Biology & Medicine,2018,15(3):299-310. 被引量:3
-
9李炜,倪才方.常见血管内栓塞材料的临床应用进展[J].中华介入放射学电子杂志,2018,6(4):347-351. 被引量:9
-
10Antonio Facciorusso.Drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma: Current state of the art[J].World Journal of Gastroenterology,2018,24(2):161-169. 被引量:27
同被引文献13
-
1蔡伟,向飞,黄耀欢,范应方,方驰华.三维可视化技术在巨块型肝癌可切除性评估及手术规划中的应用价值[J].中华消化外科杂志,2017,16(1):53-58. 被引量:43
-
2荚卫东,陈浩,葛勇胜,马金良,余继海,刘文斌,张传海,许戈良.三维可视化技术在巨块型肝细胞癌精准肝切除中的应用价值[J].中华肝脏外科手术学电子杂志,2018,7(1):35-39. 被引量:18
-
3王壮雄,李林容,王芳元,杨涛,郑嘉玲,杨剑.虚拟和增强现实技术在肝脏外科中的应用[J].实用医学杂志,2018,34(7):1210-1212. 被引量:26
-
4方驰华,赵东,曾思略.以血管为轴心的巨块型肝脏肿瘤三维可视化术前规划和诊疗[J].腹部外科,2018,31(5):299-301. 被引量:14
-
5杨剑,王壮雄,方驰华.多模态影像技术在原发性肝癌外科中的应用[J].中华肝脏外科手术学电子杂志,2019,8(1):1-5. 被引量:8
-
6钟坤雨,鞠蔚华,刘江伟,刘延,黄建钊.巨大肝癌的外科治疗策略[J].中国肝脏病杂志(电子版),2019,11(1):1-5. 被引量:8
-
7张鹏,祝文,方驰华,何松盛,曾思略,文赛,张可.多模影像技术在解剖性肝切除手术导航中应用价值研究[J].中国实用外科杂志,2019,39(5):480-486. 被引量:21
-
8赖子森,周阳,林新居,曾建兴.巨块型肝癌的精准肝切除术[J].吉林医药学院学报,2019,40(5):339-341. 被引量:3
-
9Qiang Fang,Qing-Song Xie,Jiang-Ming Chen,Shen-Liang Shan,Kun Xie,Xiao-Ping Geng,Fu-Bao Liu.Long-term outcomes after hepatectomy of huge hepatocellular carcinoma: A single-center experience in China[J].Hepatobiliary & Pancreatic Diseases International,2019,18(6):532-537. 被引量:13
-
10杨连粤.孤立性大肝癌的外科治疗进展[J].中华外科杂志,2020,58(1):13-16. 被引量:10
二级引证文献3
-
1李晓举,王星入,万丹丹,刘天锡.三维可视化联合术中超声在腹腔镜肝癌切除患者中的近期效果[J].肝胆胰外科杂志,2023,35(1):30-35. 被引量:4
-
2曹袁一诺,李里诗洛,轩辕逸睿,陈拥华.混合现实技术在肝胆胰领域中的应用进展[J].中国普外基础与临床杂志,2023,30(5):613-619. 被引量:1
-
3刘文瑛,阙园,欧阳再兴,朱剑华,吴黎明,谭勇,宋灏,朱玉珍,黄从云.末梢门静脉栓塞联合多模态影像技术在巨大肝癌外科治疗中的应用[J].实用医学杂志,2023,39(12):1546-1550.